Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Angiodynamics (ANGO) Non Operating Income (2016 - 2025)

Historic Non Operating Income for Angiodynamics (ANGO) over the last 16 years, with Q4 2025 value amounting to -$230000.0.

  • Angiodynamics' Non Operating Income fell 19349.59% to -$230000.0 in Q4 2025 from the same period last year, while for Nov 2025 it was $4.8 million, marking a year-over-year increase of 255439.56%. This contributed to the annual value of $5.9 million for FY2025, which is 82484.7% up from last year.
  • Latest data reveals that Angiodynamics reported Non Operating Income of -$230000.0 as of Q4 2025, which was down 19349.59% from -$182000.0 recorded in Q3 2025.
  • In the past 5 years, Angiodynamics' Non Operating Income ranged from a high of $5.6 million in Q1 2025 and a low of -$1.0 million during Q2 2023
  • Moreover, its 5-year median value for Non Operating Income was -$305000.0 (2023), whereas its average is -$12400.0.
  • Its Non Operating Income has fluctuated over the past 5 years, first crashed by 40869.57% in 2022, then skyrocketed by 243823.53% in 2025.
  • Quarter analysis of 5 years shows Angiodynamics' Non Operating Income stood at -$184000.0 in 2021, then plummeted by 408.7% to -$936000.0 in 2022, then skyrocketed by 153.63% to $502000.0 in 2023, then tumbled by 51.0% to $246000.0 in 2024, then crashed by 193.5% to -$230000.0 in 2025.
  • Its Non Operating Income stands at -$230000.0 for Q4 2025, versus -$182000.0 for Q3 2025 and -$322000.0 for Q2 2025.